These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 27338339)

  • 21. The Potential of Natural Products in the Management of Cardiovascular Disease.
    Singhai H; Rathee S; Jain SK; Patil UK
    Curr Pharm Des; 2024; 30(8):624-638. PubMed ID: 38477208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part II.
    Schmidt TJ; Khalid SA; Romanha AJ; Alves TM; Biavatti MW; Brun R; Da Costa FB; de Castro SL; Ferreira VF; de Lacerda MV; Lago JH; Leon LL; Lopes NP; das Neves Amorim RC; Niehues M; Ogungbe IV; Pohlit AM; Scotti MT; Setzer WN; de N C Soeiro M; Steindel M; Tempone AG
    Curr Med Chem; 2012; 19(14):2176-228. PubMed ID: 22414104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoformulations of natural products for management of metabolic syndrome.
    Taghipour YD; Hajialyani M; Naseri R; Hesari M; Mohammadi P; Stefanucci A; Mollica A; Farzaei MH; Abdollahi M
    Int J Nanomedicine; 2019; 14():5303-5321. PubMed ID: 31406461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural products against key Mycobacterium tuberculosis enzymatic targets: Emerging opportunities for drug discovery.
    Cazzaniga G; Mori M; Chiarelli LR; Gelain A; Meneghetti F; Villa S
    Eur J Med Chem; 2021 Nov; 224():113732. PubMed ID: 34399099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medicinal plants in Brazil: Pharmacological studies, drug discovery, challenges and perspectives.
    Dutra RC; Campos MM; Santos AR; Calixto JB
    Pharmacol Res; 2016 Oct; 112():4-29. PubMed ID: 26812486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current Perspectives in the Application of Medicinal Plants Against Cancer: Novel Therapeutic Agents.
    Gezici S; Şekeroğlu N
    Anticancer Agents Med Chem; 2019; 19(1):101-111. PubMed ID: 30582485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular disease with diabetes or the metabolic syndrome: should statins or fibrates be first line lipid therapy?
    Robins SJ
    Curr Opin Lipidol; 2003 Dec; 14(6):575-83. PubMed ID: 14624134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The past, present, and future of statin therapy.
    Watson KE; Fonarow GC
    Rev Cardiovasc Med; 2005; 6(3):129-39. PubMed ID: 16195686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic phytogenic compounds for obesity and diabetes.
    Jung HS; Lim Y; Kim EK
    Int J Mol Sci; 2014 Nov; 15(11):21505-37. PubMed ID: 25421245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential lipolytic regulators derived from natural products as effective approaches to treat obesity.
    Yang XD; Ge XC; Jiang SY; Yang YY
    Front Endocrinol (Lausanne); 2022; 13():1000739. PubMed ID: 36176469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current state and future perspective of cardiovascular medicines derived from natural products.
    Zhao C; Li S; Zhang J; Huang Y; Zhang L; Zhao F; Du X; Hou J; Zhang T; Shi C; Wang P; Huo R; Woodman OL; Qin CX; Xu H; Huang L
    Pharmacol Ther; 2020 Dec; 216():107698. PubMed ID: 33039419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative ethnomedicinal survey of medicinal plants given for cardiometabolic diseases by the non-institutionally trained siddha practitioners of Tiruvallur district, Tamil Nadu, India.
    Esakkimuthu S; Mutheeswaran S; Arvinth S; Paulraj MG; Pandikumar P; Ignacimuthu S
    J Ethnopharmacol; 2016 Jun; 186():329-342. PubMed ID: 27090346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New horizons for old drugs and drug leads.
    Cragg GM; Grothaus PG; Newman DJ
    J Nat Prod; 2014 Mar; 77(3):703-23. PubMed ID: 24499205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological re-assessment of traditional medicinal plants-derived inhibitors as antidotes against snakebite envenoming: A critical review.
    Puzari U; Fernandes PA; Mukherjee AK
    J Ethnopharmacol; 2022 Jun; 292():115208. PubMed ID: 35314419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Red Yeast Rice story: How to manufacture a tall tale from nature.
    Gold KR; Gold R; Avula B; Khan IA
    Eur J Prev Cardiol; 2018 Jan; 25(1):73-75. PubMed ID: 29086583
    [No Abstract]   [Full Text] [Related]  

  • 37. [STATINS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE AND DIABETES INCIDENCE--THE BENEFITS VERSUS THE RISKS].
    Lavie G; Cohen S
    Harefuah; 2015 Jun; 154(6):382-6, 404. PubMed ID: 26281083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. System-level multi-target drug discovery from natural products with applications to cardiovascular diseases.
    Zheng C; Wang J; Liu J; Pei M; Huang C; Wang Y
    Mol Divers; 2014 Aug; 18(3):621-35. PubMed ID: 24792224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HMG-CoA Reductase inhibitors: an updated review of patents of novel compounds and formulations (2011-2015).
    Oliveira EF; Santos-Martins D; Ribeiro AM; Brás NF; Cerqueira NS; Sousa SF; Ramos MJ; Fernandes PA
    Expert Opin Ther Pat; 2016 Nov; 26(11):1257-1272. PubMed ID: 27537201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of terpenes and derivatives as a new perspective for cardiovascular disease treatment: a patent review (2008-2018).
    Silva EAP; Carvalho JS; Guimarães AG; Barreto RSS; Santos MRV; Barreto AS; Quintans-Júnior LJ
    Expert Opin Ther Pat; 2019 Jan; 29(1):43-53. PubMed ID: 30583706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.